Phosphorylation of human respiratory syncytial virus P protein at serine 54 regulates viral uncoating
- Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Ctra, Majadahonda-Pozuelo Km 2, Majadahonda, Madrid 28220 (Spain)
The human respiratory syncytial virus (HRSV) structural P protein, phosphorylated at serine (S) and threonine (T) residues, is a co-factor of viral RNA polymerase. The phosphorylation of S54 is controlled by the coordinated action of two cellular enzymes: a lithium-sensitive kinase, probably glycogen synthetase kinase (GSK-3) {beta} and protein phosphatase 2A (PP2A). Inhibition of lithium-sensitive kinase, soon after infection, blocks the viral growth cycle by inhibiting synthesis and/or accumulation of viral RNAs, proteins and extracellular particles. P protein phosphorylation at S54 is required to liberate viral ribonucleoproteins (RNPs) from M protein, during the uncoating process. Kinase inhibition, late in infection, produces a decrease in genomic RNA and infectious viral particles. LiCl, intranasally applied to mice infected with HRSV A2 strain, reduces the number of mice with virus in their lungs and the virus titre. Administration of LiCl to humans via aerosol should prevent HRSV infection, without secondary effects.
- OSTI ID:
- 21141040
- Journal Information:
- Virology, Journal Name: Virology Journal Issue: 1 Vol. 380; ISSN VIRLAX; ISSN 0042-6822
- Country of Publication:
- United States
- Language:
- English
Similar Records
Molecular basis for human respiratory syncytial virus transcriptional regulator NS1 interactions with MED25
Lithium blocks ethanol-induced modulation of protein kinases in the developing brain
An intranasal recombinant NDV-BRSV Fopt vaccine is safe and reduces lesion severity in a colostrum-deprived calf model of RSV infection
Journal Article
·
Mon Mar 24 20:00:00 EDT 2025
· Nature Communications
·
OSTI ID:2553928
Lithium blocks ethanol-induced modulation of protein kinases in the developing brain
Journal Article
·
Fri Mar 14 00:00:00 EDT 2008
· Biochemical and Biophysical Research Communications
·
OSTI ID:21043657
An intranasal recombinant NDV-BRSV Fopt vaccine is safe and reduces lesion severity in a colostrum-deprived calf model of RSV infection
Journal Article
·
Wed Dec 28 19:00:00 EST 2022
· Scientific Reports
·
OSTI ID:2425583